Ironwood Investment Management’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-31,582
| Closed | -$297K | – | 171 |
|
|
2020
Q3 | $297K | Sell |
31,582
-25
| -0.1% | -$238 | 0.21% | 126 |
|
|
2020
Q2 | $242K | Sell |
31,607
-174
| -0.5% | -$1.33K | 0.19% | 128 |
|
|
2020
Q1 | $196K | Buy |
31,781
+2,001
| +7% | +$17.6K | 0.2% | 132 |
|
|
2019
Q4 | $362K | Sell |
29,780
-3,744
| -11% | -$40.9K | 0.25% | 122 |
|
|
2019
Q3 | $387K | Sell |
33,524
-95
| -0.3% | -$1K | 0.29% | 115 |
|
|
2019
Q2 | $336K | Sell |
33,619
-8
| -0% | -$86 | 0.26% | 119 |
|
|
2019
Q1 | $433K | Sell |
33,627
-435
| -1% | -$6.48K | 0.35% | 104 |
|
|
2018
Q4 | $517K | Sell |
34,062
-155
| -0.5% | -$2.95K | 0.48% | 79 |
|
|
2018
Q3 | $684K | Sell |
34,217
-42
| -0.1% | -$956 | 0.48% | 82 |
|
|
2018
Q2 | $668K | Sell |
34,259
-142
| -0.4% | -$3.14K | 0.47% | 82 |
|
|
2018
Q1 | $693K | Buy |
34,401
+330
| +1% | +$5.58K | 0.51% | 74 |
|
|
2017
Q4 | $451K | Sell |
34,071
-4,287
| -11% | -$64.6K | 0.32% | 112 |
|
|
2017
Q3 | $708K | Buy |
38,358
+4
| +0% | +$75 | 0.5% | 79 |
|
|
2017
Q2 | $706K | Sell |
38,354
-1,192
| -3% | -$23.6K | 0.51% | 77 |
|
|
2017
Q1 | $892K | Sell |
39,546
-1,355
| -3% | -$32.4K | 0.67% | 54 |
|
|
2016
Q4 | $1.42M | Sell |
40,901
-1,515
| -4% | -$45.3K | 1.04% | 25 |
|
|
2016
Q3 | $1.04M | Sell |
42,416
-3,219
| -7% | -$80.5K | 0.8% | 46 |
|
|
2016
Q2 | $1.09M | Sell |
45,635
-9,462
| -17% | -$217K | 0.82% | 48 |
|
|
2016
Q1 | $1.29M | Sell |
55,097
-36,303
| -40% | -$862K | 0.84% | 42 |
|
|
2015
Q4 | $2.76M | Sell |
91,400
-17,023
| -16% | -$550K | 1.14% | 28 |
|
|
2015
Q3 | $4.31M | Sell |
108,423
-47,071
| -30% | -$2.92M | 1.58% | 16 |
|
|
2015
Q2 | $10.7M | Sell |
155,494
-90,692
| -37% | -$5.71M | 2.47% | 1 |
|
|
2015
Q1 | $13.5M | Sell |
246,186
-16,244
| -6% | -$774K | 2.49% | 3 |
|
|
2014
Q4 | $11.2M | Sell |
262,430
-13,042
| -5% | -$471K | 2.04% | 3 |
|
|
2014
Q3 | $8.79M | Sell |
275,472
-20,986
| -7% | -$447K | 1.59% | 10 |
|
|
2014
Q2 | $6.14M | Sell |
296,458
-36,118
| -11% | -$667K | 0.98% | 44 |
|
|
2014
Q1 | $6.43M | Sell |
332,576
-23,355
| -7% | -$496K | 0.93% | 50 |
|
|
2013
Q4 | $8.64M | Buy |
355,931
+11,815
| +3% | +$278K | 1.2% | 35 |
|
|
2013
Q3 | $7.39M | Buy |
344,116
+7,612
| +2% | +$180K | 1.16% | 40 |
|
|
2013
Q2 | $7.49M | Buy |
+336,504
| New | +$7.41M | 1.33% | 29 |
|
Ironwood Investment Management's AMAG Position: Q4 2020 in Review
Ironwood Investment Management sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 31,582 shares — an estimated $297K sold.
Ironwood Investment Management first reported a position in AMAG in Q2 2013 and held it in 30 quarters. The position peaked at $13.5M in Q1 2015. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Ironwood Investment Management reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Ironwood Investment Management sold 31,582 AMAG Pharmaceuticals shares in Q4 2020, an estimated $297K.
- Ironwood Investment Management first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 30 quarters.
- Ironwood Investment Management's AMAG Pharmaceuticals position peaked at $13.5M in Q1 2015.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Ironwood Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.